Perspective Therapeutics, Inc.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 06/30/22 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | — | — | $1.4 | $0.0 | $10.8 |
| Operating income | -$113.6 | -$90.9 | -$40.9 | -$8.7 | -$6.4 |
| Net income | -$103.1 | -$79.3 | -$46.5 | -$10.8 | -$7.3 |
| Cash Flow Statement | |||||
| Free cash flow | -$95.2 | -$72.7 | -$38.0 | -$10.7 | -$8.0 |
Shares outstanding 114.2M · Free float 60.1%
Annual filing data through FY ended December 31, 2025; float as of September 19, 2026.